Related Experiment Video
Updated: Jun 16, 2026
06:15
Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Bronchiolitis: recent evidence on diagnosis and management
Joseph J Zorc1, Caroline Breese Hall
1MSCE, Children's Hospital of Philadelphia, Division of Emergency Medicine, Main AS01, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104-4399, USA. zorc@email.chop.edu
Pediatrics
|January 27, 2010
Summary
Viral bronchiolitis, a common childhood illness, requires careful management. Current evidence shows bronchodilators and corticosteroids are ineffective for routine treatment, but novel therapies show promise.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Viral bronchiolitis is a significant cause of pediatric acute illness and hospitalizations.
- Clinical practice guidelines for bronchiolitis management are evolving with ongoing research.
- Coinfections and underlying comorbidities are increasingly recognized in bronchiolitis cases.
Purpose of the Study:
- To review current evidence on the diagnosis and treatment of viral bronchiolitis in children.
- To identify predictors of severe bronchiolitis and resource utilization.
- To evaluate the efficacy of established and novel therapeutic interventions.
Main Methods:
- Systematic review of recent surveillance studies and clinical trials.
- Analysis of evidence-based reviews and expert recommendations.
- Evaluation of diagnostic and therapeutic strategies, including pulse oximetry, laboratory tests, and medications.
Main Results:
- Underlying comorbidities and young age are key predictors of severe bronchiolitis.
- Pulse oximetry is crucial for healthcare resource allocation.
- Routine use of bronchodilators and corticosteroids has shown limited efficacy.
- Diagnostic laboratory and radiographic tests have a limited role in typical cases.
Conclusions:
- Current evidence does not support routine bronchodilator or corticosteroid use for bronchiolitis.
- Novel treatments, such as nebulized hypertonic saline, show potential.
- Further research is needed to refine treatment protocols for severe cases and coinfections.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: